VANGL2
Basic information
Region (hg38): 1:160400564-160428678
Links
Phenotypes
GenCC
Source:
- neural tube defects, susceptibility to (Limited), mode of inheritance: Unknown
- neural tube defects, susceptibility to (Moderate), mode of inheritance: AD
- neural tube defects, susceptibility to (Limited), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Neural tube defects | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Musculoskeletal | 20558380; 20738329 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the VANGL2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 21 | 25 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 21 | 6 | 4 |
Variants in VANGL2
This is a list of pathogenic ClinVar variants found in the VANGL2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-160415849-G-A | VANGL2-related disorder | Likely benign (Jun 13, 2019) | ||
1-160416075-C-G | Inborn genetic diseases | Uncertain significance (Dec 02, 2022) | ||
1-160416081-C-T | VANGL2-related disorder | Likely benign (Dec 31, 2019) | ||
1-160416138-G-A | Inborn genetic diseases | Uncertain significance (Jul 06, 2021) | ||
1-160419024-C-T | Inborn genetic diseases | Uncertain significance (May 25, 2022) | ||
1-160419042-C-T | Neural tube defect | Uncertain significance (Nov 14, 2023) | ||
1-160419077-C-T | Inborn genetic diseases | Uncertain significance (Mar 06, 2023) | ||
1-160419114-A-G | Uncertain significance (Dec 01, 2021) | |||
1-160419116-T-C | Inborn genetic diseases | Uncertain significance (Jan 24, 2024) | ||
1-160419117-G-T | Inborn genetic diseases | Uncertain significance (Apr 06, 2024) | ||
1-160419119-T-C | Inborn genetic diseases | Uncertain significance (Jun 07, 2024) | ||
1-160419142-G-A | VANGL2-related disorder | Likely benign (Sep 17, 2019) | ||
1-160419212-C-T | Neural tube defect | Benign (Dec 12, 2023) | ||
1-160419317-C-T | Inborn genetic diseases | Uncertain significance (Nov 30, 2021) | ||
1-160419436-G-T | Inborn genetic diseases | Uncertain significance (Mar 26, 2024) | ||
1-160419532-G-T | Inborn genetic diseases | Uncertain significance (Mar 16, 2022) | ||
1-160419539-C-T | Inborn genetic diseases | Uncertain significance (Dec 20, 2023) | ||
1-160419593-A-C | Inborn genetic diseases | Uncertain significance (Feb 28, 2023) | ||
1-160420406-C-G | Uncertain significance (Dec 03, 2019) | |||
1-160420452-A-G | VANGL2-related disorder | Benign (Jul 10, 2019) | ||
1-160420494-A-G | Inborn genetic diseases | Uncertain significance (Jun 07, 2022) | ||
1-160420518-C-T | Inborn genetic diseases | Uncertain significance (Aug 15, 2023) | ||
1-160421085-G-A | Uncertain significance (Jan 29, 2017) | |||
1-160421100-C-T | Neural tube defect | Uncertain significance (May 28, 2021) | ||
1-160421119-C-T | Benign (Jun 08, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
VANGL2 | protein_coding | protein_coding | ENST00000368061 | 7 | 28093 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.843 | 0.157 | 125742 | 0 | 6 | 125748 | 0.0000239 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.43 | 253 | 326 | 0.777 | 0.0000234 | 3345 |
Missense in Polyphen | 77 | 126.11 | 0.6106 | 1254 | ||
Synonymous | 0.00209 | 143 | 143 | 1.00 | 0.0000100 | 1104 |
Loss of Function | 3.75 | 4 | 23.7 | 0.169 | 0.00000155 | 229 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000925 | 0.0000924 |
European (Non-Finnish) | 0.0000176 | 0.0000176 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in the control of early morphogenesis and patterning of both axial midline structures and the development of neural plate. Plays a role in the regulation of planar cell polarity, particularly in the orientation of stereociliary bundles in the cochlea. Required for polarization and movement of myocardializing cells in the outflow tract and seems to act via RHOA signaling to regulate this process. Required for cell surface localization of FZD3 and FZD6 in the inner ear (By similarity). {ECO:0000250|UniProtKB:Q91ZD4}.;
- Disease
- DISEASE: Neural tube defects (NTD) [MIM:182940]: Congenital malformations of the central nervous system and adjacent structures related to defective neural tube closure during the first trimester of pregnancy. Failure of neural tube closure can occur at any level of the embryonic axis. Common NTD forms include anencephaly, myelomeningocele and spina bifida, which result from the failure of fusion in the cranial and spinal region of the neural tube. NTDs have a multifactorial etiology encompassing both genetic and environmental components. {ECO:0000269|PubMed:20558380}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Wnt signaling pathway - Homo sapiens (human);Wnt Signaling Pathway;Signaling by WNT;Signal Transduction;Asymmetric localization of PCP proteins;PCP/CE pathway;Beta-catenin independent WNT signaling
(Consensus)
Recessive Scores
- pRec
- 0.349
Intolerance Scores
- loftool
- 0.0404
- rvis_EVS
- -1.02
- rvis_percentile_EVS
- 7.94
Haploinsufficiency Scores
- pHI
- 0.706
- hipred
- Y
- hipred_score
- 0.798
- ghis
- 0.617
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.275
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Vangl2
- Phenotype
- growth/size/body region phenotype; cellular phenotype; limbs/digits/tail phenotype; craniofacial phenotype; vision/eye phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; embryo phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; digestive/alimentary phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- vangl2
- Affected structure
- neuroepithelial cell
- Phenotype tag
- abnormal
- Phenotype quality
- mislocalised
Gene ontology
- Biological process
- establishment of planar polarity;neural tube closure;hair follicle development;heart looping;membranous septum morphogenesis;muscular septum morphogenesis;planar cell polarity pathway involved in axis elongation;Rho protein signal transduction;anterior/posterior pattern specification;heparan sulfate proteoglycan biosynthetic process;convergent extension involved in neural plate elongation;regulation of Wnt signaling pathway;glomerulus development;regulation of actin cytoskeleton organization;somatic stem cell population maintenance;cell migration involved in kidney development;post-anal tail morphogenesis;dopaminergic neuron axon guidance;serotonergic neuron axon guidance;wound healing;positive regulation of JUN kinase activity;apical protein localization;establishment or maintenance of epithelial cell apical/basal polarity;somatic stem cell division;establishment of body hair planar orientation;digestive tract morphogenesis;convergent extension involved in axis elongation;inner ear receptor cell stereocilium organization;orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis;planar dichotomous subdivision of terminal units involved in lung branching morphogenesis;lateral sprouting involved in lung morphogenesis;kidney morphogenesis;planar cell polarity pathway involved in heart morphogenesis;cochlea morphogenesis;establishment of planar polarity involved in neural tube closure;planar cell polarity pathway involved in neural tube closure;planar cell polarity pathway involved in axon guidance;non-motile cilium assembly
- Cellular component
- stress fiber;plasma membrane;cell-cell junction;integral component of membrane;basolateral plasma membrane;apical plasma membrane;lateral plasma membrane;COPII-coated ER to Golgi transport vesicle;cell pole
- Molecular function
- protein binding